| ISIN | LU2041624920 |
|---|---|
| Valor Number | 49491423 |
| Bloomberg Global ID | |
| Fund Name | JSS Sustainable Equity - Future Health P USD acc |
| Fund Provider |
J. Safra Sarasin Investmentfonds AG
Basel, Switzerland Phone: +41 58 317 44 44 Web: www.jsafrasarasin.com |
| Fund Provider | J. Safra Sarasin Investmentfonds AG |
| Representative in Switzerland |
J. Safra Sarasin Investmentfonds AG Basel Phone: +41 58 317 44 00 |
| Distributor(s) |
Bank J. Safra Sarasin AG Basel Phone: +41 58 317 44 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD). The assets of the fund are mainly invested worldwide either directly (min. 67% of the SubFund’s assets) or indirectly in equity securities that offer an exposure to one or multiple emerging and transformational health trends. The Sub-Fund invests in leading companies and niche players whose products and services contribute to the improvement of health outcome and the dampening of rising healthcare costs. |
| Peculiarities |
| Current Price * | 117.99 USD | 22.01.2026 |
|---|---|---|
| Previous Price * | 117.20 USD | 21.01.2026 |
| 52 Week High * | 118.32 USD | 07.01.2026 |
| 52 Week Low * | 90.57 USD | 08.04.2025 |
| NAV * | 117.99 USD | 22.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 143,062,730 | |
| Unit/Share Assets *** | 35,713,652 | |
| Trading Information SIX | ||
| YTD Performance | +1.70% |
31.12.2025 - 22.01.2026
31.12.2025 22.01.2026 |
|---|---|---|
| YTD Performance (in CHF) | +1.23% |
31.12.2025 - 22.01.2026
31.12.2025 22.01.2026 |
| 1 month | +1.37% |
22.12.2025 - 22.01.2026
22.12.2025 22.01.2026 |
| 3 months | +7.74% |
22.10.2025 - 22.01.2026
22.10.2025 22.01.2026 |
| 6 months | +19.80% |
22.07.2025 - 22.01.2026
22.07.2025 22.01.2026 |
| 1 year | +16.11% |
22.01.2025 - 22.01.2026
22.01.2025 22.01.2026 |
| 2 years | +19.62% |
22.01.2024 - 22.01.2026
22.01.2024 22.01.2026 |
| 3 years | +9.10% |
23.01.2023 - 22.01.2026
23.01.2023 22.01.2026 |
| 5 years | -2.92% |
22.01.2021 - 22.01.2026
22.01.2021 22.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Johnson & Johnson | 7.52% | |
|---|---|---|
| Eli Lilly and Co | 7.42% | |
| Danaher Corp | 5.98% | |
| Merck & Co Inc | 5.49% | |
| Sanofi SA | 4.94% | |
| argenx SE | 4.87% | |
| Lonza Group Ltd | 4.74% | |
| Gilead Sciences Inc | 4.58% | |
| UnitedHealth Group Inc | 4.45% | |
| Fresenius SE & Co KGaA | 3.67% | |
| Last data update | 30.11.2025 | |
| TER | 1.99% |
|---|---|
| TER date | 31.10.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 2.00% |
| Ongoing Charges *** | 1.97% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |